569 filings
10-K/A
2023 FY
AGRX
Agile Therapeutics Inc
Annual report (amended)
29 Apr 24
4:30pm
8-K
AGRX
Agile Therapeutics Inc
9 Apr 24
Results of Operations and Financial Condition
8:30am
10-K
2023 FY
AGRX
Agile Therapeutics Inc
Annual report
28 Mar 24
4:31pm
8-K
AGRX
Agile Therapeutics Inc
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
8-K
AGRX
Agile Therapeutics Inc
25 Mar 24
Agile Therapeutics Announces Delisting from Nasdaq
4:30pm
8-K
02gpm1o4339vyg
14 Mar 24
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
4:45pm
424B5
nytc7
23 Feb 24
Prospectus supplement for primary offering
4:57pm
424B5
wwj3y
23 Feb 24
Prospectus supplement for primary offering
4:55pm
8-K
cuethe
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K
n9dl8ng1
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
SC 13G/A
ozw2n1sc
13 Feb 24
AGILE THERAPEUTICS / Lind Global Fund II ownership change
8:02pm
SC 13G/A
0ej6gw
6 Feb 24
AGILE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
10:14am
8-K
6yafkll9ko matrs6zb
6 Dec 23
Other Events
8:00am
8-K
67uub13r d5egtjbljme
4 Dec 23
Entry into a Material Definitive Agreement
8:00am